Update: clinically significant cytochrome P‐450 drug interactions

EL Michalets - … : The Journal of Human Pharmacology and Drug …, 1998 - Wiley Online Library
Recent technologies have resulted in an explosion of information concerning the
cytochrome P‐450 isoenzymes and increased awareness of life‐threatening interactions' …

Venlafaxine: a review of its pharmacology and therapeutic potential in depression

SM Holliday, P Benfield - Drugs, 1995 - Springer
Synopsis Venlafaxine is a phenylethylamine derivative which facilitates neurotransmission
in the brain by blocking presynaptic reuptake of serotonin (5-hydroxytryptamine; 5-HT) and …

[KNJIGA][B] Introduction to drug metabolism

GG Gibson, P Skett - 2013 - books.google.com
Page 1 INTRODUCTION TO DRUG METABOLISM Second edition G. Gordon Gibson and
Paul Skett H SPRINGER-SCIENCE+BUSINESS MEDIA, BV Page 2 Introduction to Drug …

Differential activation of cyclophosphamide and ifosphamide by cytochromes P-450 2B and 3A in human liver microsomes

TKH Chang, GF Weber, CL Crespi, DJ Waxman - Cancer research, 1993 - aacrjournals.org
The present study identifies the specific human cytochrome P-450 (CYP) enzymes involved
in hydroxylation leading to activation of the anticancer drug cyclophosphamide and its …

Clinical pharmacokinetics of sertraline

CL De Vane, HL Liston, JS Markowitz - Clinical pharmacokinetics, 2002 - Springer
Sertraline is a naphthalenamine derivative with the predominant pharmacological action of
inhibiting presynaptic reuptake of serotonin from the synaptic cleft. It was initially marketed …

[PDF][PDF] Newer antidepressants and the cytochrome P450 system

BG Pollock - Am. J. Psychiatry, 1996 - academia.edu
Objective: This review evaluates the in vitro and in vivo evidence for inhibition of cytochrome
P450 enzymes by the newer antidepressant's and provides clinical recommendations Ior …

Depression in epilepsy: etiology, phenomenology, and treatment

MV Lambert, MM Robertson - Epilepsia, 1999 - Wiley Online Library
A history of depression or depressive symptomatology has been reported in up to two‐thirds
of patients with medically intractable epilepsy, whereas community studies have …

Clinical pharmacokinetics of selective serotonin reuptake inhibitors

J van Harten - Clinical pharmacokinetics, 1993 - Springer
A feature common to all selective serotonin reuptake inhibitors (SSRIs) is that they are
believed to act as antidepressant drugs because of their ability to reversibly block the …

SSRI-induced extrapyramidal side-effects and akathisia: implications for treatment

RM Lane - Journal of psychopharmacology, 1998 - journals.sagepub.com
The selective serotonin reuptake inhibitors (SSRIs) may occasionally induce extrapyramidal
side-effects (EPS) and/or akathisia. This maybe a consequence of serotonergically …

Influence of diet and nutritional status on drug metabolism

I Walter-Sack, U Klotz - Clinical pharmacokinetics, 1996 - Springer
Genetic and environmental factors contribute to a wide inter-and intraindividual variability in
drug metabolism. Among the environmental factors that may influence drug metabolism, the …